BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14986048)

  • 1. Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies.
    Iizuka-Mikami M; Nagai K; Yoshida K; Sugihara T; Suetsugu Y; Mikami M; Tamada T; Imai S; Kajihara Y; Fukunaga M
    Eur Radiol; 2004 Jun; 14(6):1074-81. PubMed ID: 14986048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.
    Balbo-Mussetto A; Saviolo C; Fornari A; Gottardi D; Petracchini M; Macera A; Lario CV; Gallo T; Tarella C; Cirillo S
    Radiol Med; 2017 Aug; 122(8):623-632. PubMed ID: 28421406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children.
    Kellenberger CJ; Miller SF; Khan M; Gilday DL; Weitzman S; Babyn PS
    Eur Radiol; 2004 Oct; 14(10):1829-41. PubMed ID: 15365752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.
    Altehoefer C; Blum U; Bathmann J; Wüstenberg C; Uhrmeister P; Laubenberger J; Lange W; Schwarzkopf J; Moser E; Langer M
    J Clin Oncol; 1997 May; 15(5):1754-60. PubMed ID: 9164182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
    Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
    Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
    Mouratidis B; Gilday DL; Ash JM
    Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system.
    Steinborn MM; Heuck AF; Tiling R; Bruegel M; Gauger L; Reiser MF
    J Comput Assist Tomogr; 1999; 23(1):123-9. PubMed ID: 10050822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of bone marrow infiltration by non-Hodgkin's lymphoma--comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging.
    Knauf WU; Gückel F; Döhner H; Semmler W; Trümper L; Ho AD
    Klin Wochenschr; 1991 May; 69(8):345-50. PubMed ID: 1653380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer].
    Tamada T; Nagai K; Iizuka M; Imai S; Kajihara Y; Yamamoto S; Kurebayashi J; Shimozuma K; Sonoo H; Fukunaga M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Apr; 60(5):249-54. PubMed ID: 10824532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
    Goo HW; Choi SH; Ghim T; Moon HN; Seo JJ
    Pediatr Radiol; 2005 Aug; 35(8):766-73. PubMed ID: 15864576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
    Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging.
    Hoane BR; Shields AF; Porter BA; Shulman HM
    Blood; 1991 Aug; 78(3):728-38. PubMed ID: 1859885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
    Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases.
    Widding A; Smolorz J; Franke M; Linden A; Diehl V; Schicha H
    Eur J Nucl Med; 1989; 15(5):230-8. PubMed ID: 2503382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
    Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
    Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.